187 related articles for article (PubMed ID: 12403305)
1. Quantitative structure-activity relationships study of a series of imidazole derivatives as potential new antifungal drugs.
Wiktorowicz W; Markuszewsk- M; Krysiński J; Kaliszan R
Acta Pol Pharm; 2002; 59(4):295-306. PubMed ID: 12403305
[TBL] [Abstract][Full Text] [Related]
2. Artificial neural networks in prediction of antifungal activity of a series of pyridine derivatives against Candida albicans.
Buciński A; Socha A; Wnuk M; Baczek T; Nowaczyk A; Krysiński J; Goryński K; Koba M
J Microbiol Methods; 2009 Jan; 76(1):25-9. PubMed ID: 18824043
[TBL] [Abstract][Full Text] [Related]
3. Antifungal agents. 11. N-substituted derivatives of 1-[(aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-1H-imidazole: synthesis, anti-Candida activity, and QSAR studies.
Di Santo R; Tafi A; Costi R; Botta M; Artico M; Corelli F; Forte M; Caporuscio F; Angiolella L; Palamara AT
J Med Chem; 2005 Aug; 48(16):5140-53. PubMed ID: 16078834
[TBL] [Abstract][Full Text] [Related]
4. Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives.
Zampieri D; Mamolo MG; Laurini E; Scialino G; Banfi E; Vio L
Bioorg Med Chem; 2008 Apr; 16(8):4516-22. PubMed ID: 18321714
[TBL] [Abstract][Full Text] [Related]
5. 1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies.
La Regina G; D'Auria FD; Tafi A; Piscitelli F; Olla S; Caporuscio F; Nencioni L; Cirilli R; La Torre F; De Melo NR; Kelly SL; Lamb DC; Artico M; Botta M; Palamara AT; Silvestri R
J Med Chem; 2008 Jul; 51(13):3841-55. PubMed ID: 18529046
[TBL] [Abstract][Full Text] [Related]
6. Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach.
Banfi E; Scialino G; Zampieri D; Mamolo MG; Vio L; Ferrone M; Fermeglia M; Paneni MS; Pricl S
J Antimicrob Chemother; 2006 Jul; 58(1):76-84. PubMed ID: 16709593
[TBL] [Abstract][Full Text] [Related]
7. Antifungal properties of new series of quinoline derivatives.
Musiol R; Jampilek J; Buchta V; Silva L; Niedbala H; Podeszwa B; Palka A; Majerz-Maniecka K; Oleksyn B; Polanski J
Bioorg Med Chem; 2006 May; 14(10):3592-8. PubMed ID: 16458522
[TBL] [Abstract][Full Text] [Related]
8. Correlation between antifungal activity and hydrophobicity of imidazole antifungal agents.
Hashiguchi T; Itoyama T; Kodama A; Uchida K; Yamaguchi H
Arzneimittelforschung; 1997 Nov; 47(11):1263-5. PubMed ID: 9428985
[TBL] [Abstract][Full Text] [Related]
9. QSAR modeling of the antifungal activity against Candida albicans for a diverse set of organic compounds.
Katritzky AR; Slavov SH; Dobchev DA; Karelson M
Bioorg Med Chem; 2008 Jul; 16(14):7055-69. PubMed ID: 18550376
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P450(14DM) by molecular docking and MM/PBSA method.
Zampieri D; Mamolo MG; Vio L; Banfi E; Scialino G; Fermeglia M; Ferrone M; Pricl S
Bioorg Med Chem; 2007 Dec; 15(23):7444-58. PubMed ID: 17888669
[TBL] [Abstract][Full Text] [Related]
11. Multi-target spectral moment: QSAR for antifungal drugs vs. different fungi species.
Prado-Prado FJ; Borges F; Perez-Montoto LG; González-Díaz H
Eur J Med Chem; 2009 Oct; 44(10):4051-6. PubMed ID: 19467743
[TBL] [Abstract][Full Text] [Related]
12. 3-imidazolyl-substituted flavans as potential antifungal agents: synthesis, stereochemical properties, and antifungal activity.
Emami S; Foroumadi A
Arch Pharm (Weinheim); 2009 Sep; 342(9):541-5. PubMed ID: 19598287
[TBL] [Abstract][Full Text] [Related]
13. QSARs of some novel isosteric heterocyclics with antifungal activity.
Yalçin I; Oren I; Temiz O; Sener EA
Acta Biochim Pol; 2000; 47(2):481-6. PubMed ID: 11051213
[TBL] [Abstract][Full Text] [Related]
14. Oxime and oxime ether derivatives of 1,4-benzothiazine related to oxiconazole.
Milanese L; Giacchè N; Schiaffella F; Vecchiarelli A; Macchiarulo A; Fringuelli R
ChemMedChem; 2007 Aug; 2(8):1208-13. PubMed ID: 17541993
[TBL] [Abstract][Full Text] [Related]
15. The development of 3D-QSAR study and recursive partitioning of heterocyclic quinone derivatives with antifungal activity.
Choi SY; Shin JH; Ryu CK; Nam KY; No KT; Park Choo HY
Bioorg Med Chem; 2006 Mar; 14(5):1608-17. PubMed ID: 16263301
[TBL] [Abstract][Full Text] [Related]
16. QSAR study of antimicrobial activity of some 3-nitrocoumarins and related compounds.
Debeljak Z; Skrbo A; Jasprica I; Mornar A; Plecko V; Banjanac M; Medić-Sarić M
J Chem Inf Model; 2007; 47(3):918-26. PubMed ID: 17489552
[TBL] [Abstract][Full Text] [Related]
17. Antifungal activity of artemisinin derivatives.
Galal AM; Ross SA; Jacob M; ElSohly MA
J Nat Prod; 2005 Aug; 68(8):1274-6. PubMed ID: 16124777
[TBL] [Abstract][Full Text] [Related]
18. Anion effects on anti-microbial activity of poly[1-vinyl-3-(2-sulfoethyl imidazolium betaine)].
Garg G; Chauhan GS; Gupta R; Ahn JH
J Colloid Interface Sci; 2010 Apr; 344(1):90-6. PubMed ID: 20060120
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives.
Fassihi A; Abedi D; Saghaie L; Sabet R; Fazeli H; Bostaki G; Deilami O; Sadinpour H
Eur J Med Chem; 2009 May; 44(5):2145-57. PubMed ID: 19056147
[TBL] [Abstract][Full Text] [Related]
20. Fungicidal effect of three new synthetic cationic peptides against Candida albicans.
Nikawa H; Fukushima H; Makihira S; Hamada T; Samaranayake LP
Oral Dis; 2004 Jul; 10(4):221-8. PubMed ID: 15196144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
